Ghazipur Police Seals Rs 1.85 Crore Property in Major Drug Case
In a significant crackdown on illegal drug activities, the Ghazipur police have sealed immovable property valued at Rs 1.85 crore. This property was purchased by the accused, Shubham Singh, in the name of his mother, Neelam Devi, using funds allegedly earned through the illicit trade of codeine cough syrup.
Details of the Case and Legal Proceedings
Assistant Superintendent of Police (ASP) Rakesh Mishra provided insights into the case, revealing that an FIR was registered by the Kotwali police in Ghazipur district on December 13. The charges involve multiple sections under the Bharatiya Nyaya Sanhita (BNS) and the Drugs and Cosmetics Act, including sections 206(A), 271, 276, 61(2), 338, 336(3), 318(4), 340(2) BNS, and 27(A) of the Drugs and Cosmetics Act, as well as sections 8/9(1)A(Va)/21/27A/29 of the NDPS Act.
The accused, Shubham Singh, is a resident of Dhirajotpur Bhudkuda in Ghazipur district. According to police investigations, he acquired the property from money generated through the illegal drug trade, specifically related to codeine cough syrup.
Property Freeze and Further Actions
On January 24, the property located in Mauza Dhirajot, Pargana Shadiyabad, Tehsil Jakhaniyan, was temporarily frozen. This action was carried out under the powers conferred by Section 68F of the SAFEEMA (Smugglers and Foreign Exchange Manipulators Act), adhering to established legal protocols.
The police have emphasized that further legal proceedings are underway to ensure justice is served in this case. This move highlights the authorities' commitment to combating drug-related crimes and seizing assets derived from unlawful activities.
Key Points:
- The sealed property is worth Rs 1.85 crore and was bought in the mother's name.
- The case involves serious charges under multiple acts, including the NDPS Act.
- Authorities are using legal provisions like SAFEEMA to freeze assets linked to drug trade.
- Ongoing investigations aim to dismantle networks involved in illegal drug sales.
